loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Narasin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Narasin

    DOSSIERs // Finished Dosage Forms

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: Narasin a, Compound 79891, Monteban, 55134-13-9, Antibiotic a-28086 factor a, Antibiotic c 7819b
    Molecular Formula
    C43H72O11
    Molecular Weight
    765.0  g/mol
    InChI Key
    VHKXXVVRRDYCIK-CWCPJSEDSA-N
    FDA UNII
    DZY9VU539P
    narasin is a natural product found in Kitasatospora aureofaciens with data available.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
    2.1.2 InChI
    InChI=1S/C43H72O11/c1-12-30(35(46)27(8)34(45)28(9)36-23(4)21-24(5)37(51-36)31(13-2)39(47)48)38-25(6)22-26(7)42(52-38)18-15-32(44)43(54-42)20-19-40(11,53-43)33-16-17-41(49,14-3)29(10)50-33/h15,18,23-34,36-38,44-45,49H,12-14,16-17,19-22H2,1-11H3,(H,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31+,32+,33+,34+,36+,37+,38-,40-,41+,42-,43-/m0/s1
    2.1.3 InChI Key
    VHKXXVVRRDYCIK-CWCPJSEDSA-N
    2.1.4 Canonical SMILES
    CCC(C1C(CC(C(O1)C(C)C(C(C)C(=O)C(CC)C2C(CC(C3(O2)C=CC(C4(O3)CCC(O4)(C)C5CCC(C(O5)C)(CC)O)O)C)C)O)C)C)C(=O)O
    2.1.5 Isomeric SMILES
    CC[C@H]([C@H]1[C@H](C[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    DZY9VU539P
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 4-methylsalinomycin

    2. Narasin A

    3. Narasin Monosodium Salt

    2.3.2 Depositor-Supplied Synonyms

    1. Narasin A

    2. Compound 79891

    3. Monteban

    4. 55134-13-9

    5. Antibiotic A-28086 Factor A

    6. Antibiotic C 7819b

    7. Antibiotic A 28086a

    8. Salinomycin, 4-methyl-, (4s)-

    9. Lilly 79891

    10. 4-methylsalinomycin

    11. C-7819b

    12. Dzy9vu539p

    13. Narasine

    14. Narasino

    15. Narasinum

    16. Compd-79891

    17. C 7819b

    18. Salinomycin, 4-methyl-, (4s)

    19. Monteban (tn)

    20. Narasine [inn-french]

    21. Narasinum [inn-latin]

    22. Narasino [inn-spanish]

    23. Narasin (usp/inn)

    24. (2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(3s,5s,7r,9s,10s,12r,15r)-3-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic Acid

    25. Unii-dzy9vu539p

    26. Brn 1678311

    27. Ai3-29798

    28. Narasin [usan:usp:inn:ban]

    29. Narasin 100 Microg/ml In Acetonitrile

    30. Ncgc00167550-01

    31. 2h-pyran-2-acetic Acid, Alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-

    32. Narasin [usan]

    33. Narasin [inn]

    34. Narasin [mi]

    35. Narasin [mart.]

    36. Narasin [usp-rs]

    37. Dsstox_cid_26707

    38. Dsstox_rid_81840

    39. Dsstox_gsid_46707

    40. Narasin [green Book]

    41. Alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-2h-pyran-2-acetic Acid

    42. Schembl123401

    43. Narasin [usp Impurity]

    44. Chembl2104423

    45. Dtxsid2046707

    46. Gtpl10835

    47. Chebi:183815

    48. Tox21_112545

    49. Zinc85540282

    50. Db11432

    51. Ncgc00167550-06

    52. Ncgc00167550-08

    53. Cas-55134-13-9

    54. Hy-121410

    55. Cs-0081972

    56. D05122

    57. Q2104314

    58. (2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(3s,5s,7r,9s,10s,12r,15r)-3-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 765.0 g/mol
    Molecular Formula C43H72O11
    XLogP36.2
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count12
    Exact Mass764.50746311 g/mol
    Monoisotopic Mass764.50746311 g/mol
    Topological Polar Surface Area161 Ų
    Heavy Atom Count54
    Formal Charge0
    Complexity1360
    Isotope Atom Count0
    Defined Atom Stereocenter Count19
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Bacterial Agents

    Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

    Coccidiostats

    Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)

    Post Enquiry
    POST ENQUIRY